Child and Adolescent Psychiatry Academy
November 6, 2024
Every year NEI Fall Congress kicks off with multiple pre-conference...
Read More
Disrupted Access to Prescription Stimulant Medications
August 12, 2024
The Centers for Disease Control and Prevention (CDC) recently issue...
Read More
Variation In The Effect Of Antipsychotics In Children And Adolescents
July 30, 2024
Despite therapeutic benefits, antipsychotic treatments are often as...
Read More
FDA Approves Pitolisant for Excessive Daytime Sleepiness in Pediatric Narcolepsy
June 25, 2024
The U.S. Food and Drug Administration has approved a new treatment ...
Read More
Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder
June 21, 2024
Bipolar disorder (BD) often appears after onset of major depressive...
Read More
TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
April 23, 2024
The FDA has recently granted clearance of a transcranial magnetic s...
Read More
Stimulants and Sleep Difficulties in Pediatric ADHD
March 28, 2024
A recent comprehensive study delved into the long-term effects of m...
Read More
CBT Helps Hyperactive Brain Circuits In Pediatric Patients With Anxiety Disorders
February 16, 2024
A new study reveals that cognitive behavioral therapy (CBT) normali...
Read More
Antipsychotic Medications and Mortality in Children and Young Adults
December 15, 2023
Children and young adults are commonly prescribed antipsychotics, p...
Read More
STAR-D For Adolescents?
December 8, 2023
Major depressive disorder (MDD) among adolescents carries high morb...
Read More
Highlights from 2023 NEI Congress: Child and Adolescent Psychiatry Academy
November 8, 2023
This year’s Child and Adolescent Psychiatry Academy included a seri...
Read More
Childhood Adversity and the Cortisol Awakening Response in Depression
August 3, 2023
The hypothalamic pituitary adrenal (HPA) axis is the main regulator...
Read More